Barbara G. Painter

960 total citations
24 papers, 800 citations indexed

About

Barbara G. Painter is a scholar working on Endocrinology, Pharmacology and Epidemiology. According to data from OpenAlex, Barbara G. Painter has authored 24 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, 5 papers in Pharmacology and 5 papers in Epidemiology. Recurrent topics in Barbara G. Painter's work include Enterobacteriaceae and Cronobacter Research (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Barbara G. Painter is often cited by papers focused on Enterobacteriaceae and Cronobacter Research (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Barbara G. Painter collaborates with scholars based in United States and Mexico. Barbara G. Painter's co-authors include Henry D. Isenberg, Mario Ángel-González, Arzu Selen, Peter G. Welling, E. Edward Evans, Ronald T. Acton, Peter F. Weinheimer, George L. Drusano, Sue H. Duran and Alan Forrest and has published in prestigious journals such as Journal of Bacteriology, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Barbara G. Painter

24 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara G. Painter United States 14 292 253 229 213 197 24 800
P. Van der Auwera Belgium 15 260 0.9× 260 1.0× 209 0.9× 173 0.8× 151 0.8× 41 713
C E Fasching United States 14 225 0.8× 195 0.8× 125 0.5× 94 0.4× 181 0.9× 22 575
A Contrepois France 16 278 1.0× 424 1.7× 385 1.7× 122 0.6× 110 0.6× 32 804
K. Dornbusch Sweden 16 306 1.0× 305 1.2× 214 0.9× 200 0.9× 593 3.0× 47 1.1k
Mark W. Garrison United States 15 298 1.0× 289 1.1× 356 1.6× 296 1.4× 232 1.2× 33 909
William J. Ritz United States 17 144 0.5× 290 1.1× 446 1.9× 142 0.7× 153 0.8× 43 754
H. Mittermayer Austria 17 111 0.4× 250 1.0× 324 1.4× 185 0.9× 204 1.0× 46 843
C. C. Sanders United States 15 304 1.0× 197 0.8× 116 0.5× 122 0.6× 488 2.5× 29 810
R L Kaplan United States 12 81 0.3× 298 1.2× 256 1.1× 161 0.8× 117 0.6× 17 616
J. P. Maskell United Kingdom 17 150 0.5× 263 1.0× 195 0.9× 86 0.4× 174 0.9× 35 705

Countries citing papers authored by Barbara G. Painter

Since Specialization
Citations

This map shows the geographic impact of Barbara G. Painter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara G. Painter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara G. Painter more than expected).

Fields of papers citing papers by Barbara G. Painter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara G. Painter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara G. Painter. The network helps show where Barbara G. Painter may publish in the future.

Co-authorship network of co-authors of Barbara G. Painter

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara G. Painter. A scholar is included among the top collaborators of Barbara G. Painter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara G. Painter. Barbara G. Painter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Church, Deborah, Robert J. Kuhn, Thomas Rubio, et al.. (1997). Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Pediatric Infectious Disease Journal. 16(1). 97–105. 63 indexed citations
2.
Baddour, Larry M., et al.. (1995). Risk Factor Assessment for the Acquisition of Fluoroquinolone-Resistant Isolates of Pseudomonas aeruginosa in a Community-Based Hospital. Microbial Drug Resistance. 1(3). 219–222. 15 indexed citations
3.
Painter, Barbara G., et al.. (1993). Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. Journal of Clinical Microbiology. 31(5). 1280–1285. 202 indexed citations
4.
Barry, A L, Robert J. Fass, H. C. Neu, et al.. (1985). Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks. Journal of Clinical Microbiology. 21(6). 880–883. 32 indexed citations
5.
Ángel-González, Mario, et al.. (1985). Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers. Antimicrobial Agents and Chemotherapy. 28(2). 235–239. 60 indexed citations
6.
Ángel-González, Mario, et al.. (1984). Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers. Antimicrobial Agents and Chemotherapy. 26(5). 741–744. 160 indexed citations
7.
Isenberg, Henry D., et al.. (1975). Primary Osteomyelitis Due to an Anaerobic Microorganism. American Journal of Clinical Pathology. 64(3). 385–388. 8 indexed citations
8.
Painter, Barbara G. & Henry D. Isenberg. (1975). Clinical Laboratory Evaluation of the Fifty-Milliliter Vacutainer Blood Culture Tube. Journal of Clinical Microbiology. 2(2). 99–103. 8 indexed citations
9.
Isenberg, Henry D., et al.. (1974). r/b Expanders: Their Use in Identifying Routinely and Unusually Reacting Members of Enterobacteriaceae. Applied Microbiology. 27(3). 575–583. 2 indexed citations
10.
Painter, Barbara G. & Henry D. Isenberg. (1973). Clinical Laboratory Experience with the Improved Enterotube. Applied Microbiology. 25(6). 896–899. 18 indexed citations
11.
Painter, Barbara G. & Henry D. Isenberg. (1973). Isolation ofCandida parapsilosis:Report of Two Cases. American Journal of Clinical Pathology. 59(1). 62–65. 19 indexed citations
12.
Isenberg, Henry D., et al.. (1973). Clinical Laboratory Study of Cephacetrile and Cephalothin Against Bacteria Recently Isolated from Clinical Specimen. American Journal of Clinical Pathology. 59(5). 700–705. 4 indexed citations
13.
Painter, Barbara G. & Henry D. Isenberg. (1973). Clinical Laboratory Experience with the Improved Enterotube. Applied Microbiology. 25(6). 896–899. 4 indexed citations
14.
Isenberg, Henry D. & Barbara G. Painter. (1971). Comparison of Conventional Methods, the R/B System, and Modified R/B System as Guides to the Major Divisions of Enterobacteriaceae. Applied Microbiology. 22(6). 1126–1134. 13 indexed citations
15.
Weinheimer, Peter F., E. Edward Evans, Robert M. Stroud, Ronald T. Acton, & Barbara G. Painter. (1969). Comparative Immunology: Natural Hemolytic System of the Spiny Lobster, Panulirus argus. Experimental Biology and Medicine. 130(1). 322–326. 19 indexed citations
16.
Evans, E. Edward, et al.. (1969). Secondary and Tertiary Responses of the Induced Bactericidin from the West Indian Spiny Lobster,Panulirus argus. Journal of Bacteriology. 98(3). 943–946. 20 indexed citations
17.
Evans, E. Edward, et al.. (1968). An Induced Bactericidin in the Spiny Lobster, Panulirus argus. Experimental Biology and Medicine. 128(2). 394–398. 50 indexed citations
18.
Sigel, M. Michael, et al.. (1968). T2 Bacteriophage Clearance in the Lemon Shark. Experimental Biology and Medicine. 128(4). 977–979. 3 indexed citations
19.
Evans, E. Edward, et al.. (1967). Complement-dependent systems and the phylogeny of immunity. In Vitro Cellular & Developmental Biology - Plant. 3(1). 146–153. 11 indexed citations
20.
Painter, Barbara G., et al.. (1963). EFFECTS OF SODIUM CAPRYLATE ONCANDIDA ALBICANSI. Journal of Bacteriology. 86(3). 548–557. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026